Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00437164 · ClinicalTrials.gov registry record · Phase 2
A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus
A Phase 2 study, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00437164: Clinical Trial Phase 2 study, sponsored by GlaxoSmithKline.
NCT00437164 is a Phase 2 study that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00437164, a Phase 2 study, was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Many drugs used for the treatment of Type 2 Diabetes Mellitus cause the body to retain water. This study will assess whether or not GW677954 causes the body to retain fluid.
Interventions
- DRUG Insulin
- DRUG Oral GW677954 Capsules (15 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2006-09 |
| Est. Completion | 2006-11 |
| Phase | Phase 2 |
Why NCT00437164 stopped before completion
NCT00437164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Insulin is the first listed.
NCT00437164 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00437164 about?
NCT00437164 is a clinical study titled "A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus". Many drugs used for the treatment of Type 2 Diabetes Mellitus cause the body to retain water. This study will assess whether or not GW677954 causes the body to retain fluid.
What is the current status of trial NCT00437164?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2006-09. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00437164?
The interventions under investigation include: Insulin (DRUG), Oral GW677954 Capsules (15 mg) (DRUG).
Who is sponsoring clinical trial NCT00437164?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00437164's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia